Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Passage Bio, Inc. (PASG)  
$0.40 0.00 (0.00%) as of 4:30 Fri 7/11


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 45,530,000
Market Cap: 18.25(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2666 - $1.13
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Passage Bio is a genetic medicines company focused on developing therapies for monogenic central nervous system disorders. Co. is developing PBGM01, which utilizes a proprietary AAVhu68 capsid for the treatment of GM1 gangliosidosis. Co. is also developing PBFT02, which utilizes an AAV1 capsid for the treatment of frontotemporal dementia-progranulin deficiency. Co. is also developing PBKR03, which utilizes a proprietary AAVhu68 capsid for the treatment of Krabbe disease. Co. has various programs in the research stage under its license agreement with the Trustees of the University of Pennsylvania including: PBML04 for metachromatic leukodystrophy and PBAL05 for amyotrophic lateral sclerosis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 128,848 128,848 958,846 958,846
Total Buy Value $733,826 $733,826 $1,259,383 $1,259,383
Total People Bought 1 1 1 1
Total Buy Transactions 3 3 7 7
Total Shares Sold 583,657 968,283 1,970,840 2,016,246
Total Sell Value $197,239 $325,675 $1,015,039 $1,056,546
Total People Sold 1 1 2 4
Total Sell Transactions 3 9 26 31
End Date 2025-05-22 2025-02-18 2024-08-20 2023-08-21

   
Records found: 96
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Nichols Weston 10% Owner   –       –       •   2025-07-24 4 B $5.71 $379,455 I/I 66,423 591,696 1.5     -
   Nichols Weston 10% Owner   –       –       •   2025-07-23 4 B $5.74 $283,033 I/I 49,302 525,273 1.5     -
   Nichols Weston 10% Owner   –       –       •   2025-07-22 4 B $5.44 $71,338 I/I 13,123 475,971 1.5     -
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-06-26 4 S $0.33 $70,375 I/I (213,257) 6,066,343 -21%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-06-25 4 S $0.33 $45,804 I/I (138,800) 6,279,600 -23%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-06-24 4 S $0.35 $81,060 I/I (231,600) 6,418,400 -14%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-04-24 4 S $0.32 $21,822 I/I (68,195) 6,650,000 -23%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-04-23 4 S $0.34 $30,372 I/I (89,328) 6,718,195 -19%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-04-22 4 S $0.34 $26,537 I/I (78,049) 6,807,523 -15%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-04-17 4 S $0.33 $25,440 I/I (77,090) 6,885,572 -21%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-04-16 4 S $0.33 $20,341 I/I (61,638) 6,962,662 -22%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-04-15 4 S $0.38 $3,924 I/I (10,326) 7,024,300 -9%     
   Borthwick Kathleen CFO   •       –      –    2025-02-11 4 S $0.53 $1,686 D/D (3,183) 41,283 37%     
   Borthwick Kathleen CFO   •       –      –    2025-02-10 4 OE $0.00 $0 D/D 8,000 44,466     -
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-01-14 4 S $0.60 $47,414 I/I (79,024) 7,034,626 38%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-01-13 4 S $0.64 $11,511 I/I (17,986) 7,113,650 45%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-01-10 4 S $0.66 $83,298 I/I (126,209) 7,131,636 55%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-01-08 4 S $0.68 $51,005 I/I (75,007) 7,257,845 52%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-01-07 4 S $0.71 $37,301 I/I (52,536) 7,332,852 57%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2025-01-06 4 S $0.77 $15,000 I/I (19,481) 7,385,388 60%     
   Nichols Weston 10% Owner   –       –       •   2024-12-27 4 B $0.65 $241,038 I/I 373,645 9,256,953 1.5 -50%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2024-12-20 4 S $0.60 $138,193 I/I (230,321) 7,404,869 46%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2024-12-11 4 S $0.80 $64 I/I (80) 7,635,190 57%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2024-12-10 4 S $0.80 $6,412 I/I (8,015) 7,635,270 58%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2024-12-09 4 S $0.84 $45,512 I/I (54,181) 7,643,285 56%     
  96 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us